You might be a candidate if you have: A history of heart attack or stroke Coronary artery disease Heart failure Multiple risk factors for cardiovascular disease Research suggests these medications may help reduce the risk of major adverse cardiovascular events, though studies specific to Mounjaros cardiovascular benefits are still ongoing
Drug Compounding and Drug Shortages
Avoid semaglutide if you have a history of certain conditions like medullary thyroid cancer, gallbladder disease, pancreatitis, or multiple endocrine neoplasia syndrome type 2 (MEN2)
Presented for research literature review only Arushanian EB et al
Diarrhea Less common than constipation, but it can occur, especially in the early stages
The glucose-dependent nature of semaglutides insulin secretion generally results in a lower intrinsic risk of hypoglycemia compared to insulin or sulfonylureas, but the combination effect must be carefully managed